← Back to patent-cliff list
CAS 30804-52-5
ethyl (2S)-2-acetamido-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
Codes: Levothyroxine Sodium-005
Application context (from source-drug indications)
ComaLevothyroxine Sodium粘液性水肿昏迷Levothyroxine SodiumHypothyroidismLevothyroxine SodiumThyroid cancerLevothyroxine SodiumHyperthyroidismLevothyroxine SodiumObesityLevothyroxine Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Levothyroxine Sodium | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid→3,5-Diiodo-L-tyrosine→(2S)-2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid→Ethyl N-acetyl-3,5-diiodo-L-tyrosinate→ethyl (2S)-2-acetamido-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.